Mortality before hospital discharge · preterm infants
Higher showed no clear difference in mortality to hospital discharge compared with lower amino acid intake (low certainty).
1 finding from 1 review
Neurodevelopmental disability · preterm infants
It is very uncertain whether higher changes neurodevelopmental disability compared with lower amino acid intake (very low certainty).
1 finding from 1 review
Postnatal growth failure (weight < 10th percentile) · preterm infants
It is very uncertain whether higher changes postnatal growth failure at discharge (weight < 10th centile) compared with lower amino acid intake (very low certainty).
1 finding from 1 review
Weight gain · preterm infants
1 finding from 1 review
Head circumference gain (mm/week) · preterm infants
1 finding from 1 review
Abnormal blood urea nitrogen (various criteria) · preterm infants
Higher leads to higher abnormal blood urea nitrogen (various criteria) compared with lower amino acid intake (high certainty).
1 finding from 1 review
Resolution of purulent secretion · acute rhinosinusitis in adults, whether clinically diagnosed or confirmed by imaging
Antibiotics leads to higher severity or duration of different clinical symptoms: resolution of… compared with placebo (high certainty).
1 finding from 1 review
Side effects – overall · acute rhinosinusitis in adults, whether clinically diagnosed or confirmed by imaging
Antibiotics leads to higher side effects: total compared with placebo (high certainty).
1 finding from 1 review
Interventions side effects: diarrhoea · acute rhinosinusitis in adults, whether clinically diagnosed or confirmed by imaging
Antibiotics leads to higher side effects: diarrhoea compared with placebo (high certainty).
1 finding from 1 review
Clinical failure · acute rhinosinusitis in adults, whether clinically diagnosed or confirmed by imaging
Antibiotics leads to lower clinical failure compared with placebo (high certainty).
1 finding from 1 review
Visual improvement at end of treatment, as defined by two or more Snellen lines · people with diabetic retinopathy
Single herb plus conventional intervention may leads to higher visual acuity (gain of ≥ 2 lines) (end of treatment) compared with conventional intervention (low certainty).
1 finding from 1 review
Reduction in microaneurysms · people with diabetic retinopathy
It is very uncertain whether single herb plus conventional intervention changes reduction in microaneurysms compared with conventional intervention (very low certainty).
1 finding from 1 review
Observations in retina: reduction in haemorrhages · people with diabetic retinopathy
It is very uncertain whether single herb plus conventional intervention changes observations in retina: reduction in haemorrhages compared with conventional intervention (very low certainty).
1 finding from 1 review
HbA1c (%) · people with diabetic retinopathy
1 finding from 1 review
Adverse outcomes · people with diabetic retinopathy
1 finding from 1 review
All‐cause mortality at 1 year · people with advanced biliary tract carcinomas
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall response rate · people with advanced biliary tract carcinomas
It is very uncertain whether gemcitabine changes overall response rate compared with vandetanib (very low certainty).
1 finding from 1 review
Time to progression of the tumour · people with advanced biliary tract carcinomas
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Grade 1 ‐ 4 anaemia · people with advanced biliary tract carcinomas
It is very uncertain whether gemcitabine changes grade 1 ‐ 4 anaemia compared with vandetanib (very low certainty).
1 finding from 1 review
All‐cause mortality at 1 year · people with advanced biliary tract carcinomas
It is very uncertain whether gemcitabine plus cisplatin changes all‐cause mortality at 1 year compared with S‐1 plus cisplatin (very low certainty).
1 finding from 1 review